Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1010651632354PMID 11519865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients.

  2000cited by this paper
• Mammaglobin expression in primary, metastatic, and occult breast cancer.

  1999cited by this paper
• Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.

  1999cited by this paper
• Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells

  1999cited by this paper
• Correlation between p53, c‐erbB‐2, and topoisomerase IIα expression, DNA ploidy, hormonal receptor status and proliferation in 356 node‐negative breast carcinomas: prognostic implications

  1999cited by this paper
• Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription‐polymerase chain reaction

  1999cited by this paper
• MUC1 expression in hematopoietic tissues.

  1999cited by this paper
• Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study.

  1999cited by this paper
• Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up

  1998cited by this paper
• Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients.

  1998cited by this paper
• Increased sensitivity for detection of micrometastases in bone‐marrow/peripheral‐blood stem‐cell products from breast‐cancer patients by negative immunomagnetic separation

  1998cited by this paper
• Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

  1998cited by this paper
• Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.

  1998cited by this paper
• The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.

  1997cited by this paper
• Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.

  1997cited by this paper
• Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.

  1996cited by this paper
• Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.

  1996cited by this paper
• Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations

  1994cited by this paper
• Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.

  1994cited by this paper
• Age as prognostic factor in premenopausal breast carcinoma.

  1993cited by this paper
• Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

  1991cited by this paper
• Micrometastases in breast cancer: long-term follow-up of the first patient cohort.

  1991cited by this paper
• Pathologic findings from the national surgical adjuvant breast and bowel projects (NSABP) prognostic discriminants for 8‐year survival for node‐negative invasive breast cancer patients

  1990cited by this paper
• Failure of tetrachlorodecaoxygen anion complex to assist wound healing.

  1989cited by this paper
• Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.

  1987cited by this paper
• Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

  1983cited by this paper
• Detection of micrometastases in patients with primary breast cancer.

  1983cited by this paper

• La performance diagnostique des marqueurs tumoraux messagers dans le diagnostic et le suivi du cancer du sein

  2014cites this paper
• Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients

  2014cites this paper
• Expression of human mammaglobin as a marker of bone marrow micrometastasis in breast cancer.

  2012cites this paper
• Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.

  2010cites this paper
• CK 19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance

  2010cites this paper
• Positive Bone Marrow Biopsy Is Associated with a Decreased Disease-Free Survival in Patients with Operable Breast Cancer

  2010cites this paper
• CK19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance.

  2010cites this paper
• A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow

  2009cites this paper
• Positive Bone Marrow Biopsy Is Associated with a Decreased Disease-Free Survival in Patients with Operable Breast Cancer

  2009cites this paper
• Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: Interim results of a prospective cohort study

  2008cites this paper
• Is human mRNA mammaglobin-1 a good marker of carcinoma cells in the peripheral blood of patients with breast cancer?

  2008cites this paper
• Recent advances in the detection of bone marrow micrometastases: A promising area for research or just another false hope? A review of the literature

  2007cites this paper
• The clinical significance of disseminated tumor cells in breast cancer

  2007cites this paper
• Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.

  2006cites this paper
• Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

  2006cites this paper
• Bone marrow and sentinel lymph node biopsy in patients with breast cancer: from staging to ultrastaging?

  2006cites this paper
• Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.

  2005cites this paper
• Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.

  2005cites this paper
• Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.

  2004cites this paper
• Mammaglobin-based strategies for treatment of breast cancer.

  2004cites this paper
• Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

  2004cites this paper
• Mammaglobin: a candidate diagnostic marker for breast cancer.

  2004cites this paper
• Stanniocalcin-1 : A Novel Molecular Blood and Bone Marrow Marker for Human Breast Cancer 1

  2003cites this paper
• Functional relationship and gene ontology classification of breast cancer biomarkers.

  2003cites this paper
• Bone marrow micrometastasis detected by RT-PCR in esophageal squamous cell carcinoma.

  2003cites this paper
• A novel method for increasing the expression level of recombinant proteins.

  2003cites this paper
• Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer.

  2003cites this paper
• Functional Relationship and Gene Ontology Classification of Breast Cancer Biomarkers

  2003cites this paper
• Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers.

  2002cites this paper
• Molecular markers in the diagnosis and staging of breast cancer.

  2002cites this paper
• Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.

  2002cites this paper
• Mammaglobin Expression in Gynecologic Malignancies and Malignant Effusions Detected by Nested Reverse Transcriptase-Polymerase Chain Reaction

  2002cites this paper
• Prognostic value of tumour cell detection in peripheral blood of breast cancer patients.

  2002cites this paper